Cardioprotective effect of valsartan in mice with short-term high-salt diet by regulating cardiac aquaporin 1 and angiogenic factor expression

Cardiovasc Pathol. 2015 Jul-Aug;24(4):224-9. doi: 10.1016/j.carpath.2014.12.003. Epub 2014 Dec 27.

Abstract

Hypertension is the most common risk factor for various cardiovascular and cerebrovascular diseases that affects approximately 61 million, or 25% of the population in United States. The dietary salt intake is one of the most important but modifiable factors for hypertension. In the current study, we aim to elucidate the role of aquaporin 1 in high-salt-induced hypertension and cardiac injuries and whether angiotensin II receptor blocker valsartan could ameliorate the effect of high salt on blood pressure. Mice were fed with normal diet, high-salt diet in the presence or absence of valsartan for 4 weeks. The body weight gain, feeding behavior, blood pressure, and cardiac pathology changes were monitored after 4 weeks. The expression of aquaporin 1, vascular endothelial growth factor, transforming growth factor β1, and basic fibroblast growth factor were analyzed using quantitative real-time polymerase chain reaction, Western blot, and immunohistochemical staining. Valsartan partially reversed the effects of high-salt diet on hypertension, cardiac injuries such as fibrosis and inflammatory cell infiltration, and inhibition of aquaporin 1 and angiogenic factors; valsartan alone did not exert such effects. The current data demonstrated that the reduction of cardiac aquaporin 1 and angiogenic factor expression level might be associated with high-salt-induced hypertension and cardiac injuries in mice, which could be ameliorated by angiotensin II receptor blocker treatment.

Keywords: Angiotensin II receptor blocker; Aquaporin 1; Cardiac injury; High salt; Hypertension; Valsartan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenic Proteins / genetics
  • Angiogenic Proteins / metabolism*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology*
  • Animals
  • Antihypertensive Agents / pharmacology*
  • Aquaporin 1 / genetics
  • Aquaporin 1 / metabolism*
  • Blood Pressure / drug effects
  • Cytokines / metabolism
  • Cytoprotection
  • Disease Models, Animal
  • Feeding Behavior / drug effects
  • Fibrosis
  • Heart Diseases / etiology
  • Heart Diseases / genetics
  • Heart Diseases / metabolism
  • Heart Diseases / pathology
  • Heart Diseases / physiopathology
  • Heart Diseases / prevention & control*
  • Hypertension / drug therapy*
  • Hypertension / etiology
  • Hypertension / metabolism
  • Hypertension / physiopathology
  • Male
  • Mice, Inbred C57BL
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • Sodium Chloride, Dietary*
  • Time Factors
  • Valsartan / pharmacology*
  • Weight Gain / drug effects

Substances

  • Angiogenic Proteins
  • Angiotensin II Type 1 Receptor Blockers
  • Antihypertensive Agents
  • Aqp1 protein, mouse
  • Cytokines
  • Sodium Chloride, Dietary
  • Aquaporin 1
  • Valsartan